{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T17:16:39Z","timestamp":1778087799928,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.humpath.2026.106105","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T07:26:50Z","timestamp":1773646010000},"page":"106105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["RNA NGS testing provides additional diagnostic and prognostic information over metaphase karyotyping in routine clinical evaluation of acute leukemias and chronic myeloid neoplasms"],"prefix":"10.1016","volume":"172","author":[{"given":"Shikha","family":"Malhotra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng Jin","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-8085","authenticated-orcid":false,"given":"James R.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2026.106105_bib1","series-title":"The international consensus classification of myeloid and lymphoid neoplasms","year":"2025"},{"key":"10.1016\/j.humpath.2026.106105_bib2","series-title":"Haematolymphoid tumours","author":"Board","year":"2024"},{"key":"10.1016\/j.humpath.2026.106105_bib3","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1001\/jama.2025.0220","article-title":"Chronic myeloid leukemia: a review","volume":"333","author":"Jabbour","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.humpath.2026.106105_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.35953","article-title":"Management of chronic myeloid leukemia in 2025","volume":"131","author":"Kantarjian","year":"2025","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2026.106105_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/cge.13372","article-title":"Pathogenetic implication of fusion genes in acute promyelocytic leukemia and their diagnostic utility","volume":"95","author":"Baba","year":"2019","journal-title":"Clin Genet"},{"key":"10.1016\/j.humpath.2026.106105_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.exphem.2025.104822","article-title":"Advances in RARalpha fusion genes in acute promyelocytic leukemia","volume":"149","author":"Zhang","year":"2025","journal-title":"Exp Hematol"},{"key":"10.1016\/j.humpath.2026.106105_bib7","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/stem.3263","article-title":"Clinical and molecular consequences of fusion genes in myeloid malignancies","volume":"38","author":"Matsukawa","year":"2020","journal-title":"Stem Cell"},{"key":"10.1016\/j.humpath.2026.106105_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16234055","article-title":"Fusion genes in myeloid malignancies","volume":"16","author":"Ang","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2026.106105_bib9","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood.V85.12.3662.bloodjournal85123662","article-title":"The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion","volume":"85","author":"Romana","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106105_bib10","first-page":"1985","article-title":"TEL\/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis","volume":"9","author":"Shurtleff","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2026.106105_bib11","doi-asserted-by":"crossref","first-page":"9585","DOI":"10.1038\/s41598-022-13545-y","article-title":"FISH improves risk stratification in acute leukemia by identifying KMT2A abnormal copy number and rearrangements","volume":"12","author":"Li","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.humpath.2026.106105_bib12","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1038\/s41375-024-02333-4","article-title":"Rearrangements involving 11q23.3\/KMT2A in adult AML: mutational landscape and prognostic implications - a HARMONY study","volume":"38","author":"Hernandez-Sanchez","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2026.106105_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-6703-2_1","article-title":"Cancer cytogenetics: an introduction","volume":"1541","author":"Wan","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.humpath.2026.106105_bib14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3343\/alm.2014.34.6.413","article-title":"Cancer cytogenetics: methodology revisited","volume":"34","author":"Wan","year":"2014","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.humpath.2026.106105_bib15","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1309\/AJCPW10YBRMWSWYE","article-title":"Diagnostic yield of bone marrow and peripheral blood FISH panel testing in clinically suspected myelodysplastic syndromes and\/or acute myeloid leukemia: a prospective analysis of 433 cases","volume":"135","author":"Coleman","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2026.106105_bib16","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood.2022015854","article-title":"Genomic profiling for clinical decision making in lymphoid neoplasms","volume":"140","author":"de Leval","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106105_bib17","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood.2022015853","article-title":"Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia","volume":"140","author":"Duncavage","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106105_bib18","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/s41467-019-09374-9","article-title":"Diagnosis of fusion genes using targeted RNA sequencing","volume":"10","author":"Heyer","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2026.106105_bib19","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2141.2006.06301.x","article-title":"The MLL partial tandem duplication in acute myeloid leukaemia","volume":"135","author":"Basecke","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2026.106105_bib20","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/s41375-023-01877-1","article-title":"The KMT2A recombinome of acute leukemias in 2023","volume":"37","author":"Meyer","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2026.106105_bib21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3324\/haematol.2017.185603","article-title":"The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia","volume":"103","author":"Marke","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2026.106105_bib22","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s00277-023-05250-1","article-title":"Prevalence and prognostic significance of IKZF1 deletion in paediatric acute lymphoblastic leukemia: a systematic review and meta-analysis","volume":"102","author":"Srinivasan","year":"2023","journal-title":"Ann Hematol"},{"key":"10.1016\/j.humpath.2026.106105_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.humpath.2026.106105_bib24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/gcc.23051","article-title":"A novel HNRNPH1::ERG rearrangement in aggressive acute myeloid leukemia","volume":"61","author":"Jiang","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2026.106105_bib25","article-title":"The adult HNRNPH1::ERG positive acute myeloid leukemia with clear lower remission and worse prognosis: a case report and review of the literature","volume":"104","author":"Lu","year":"2025","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.humpath.2026.106105_bib26","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/gcc.22741","article-title":"Acute leukemias harboring KMT2A\/MLLT10 fusion: a 10-year experience from a single genomics laboratory","volume":"58","author":"Peterson","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2026.106105_bib27","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","year":"2008"},{"key":"10.1016\/j.humpath.2026.106105_bib28","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000250","article-title":"A simple RNA target capture NGS strategy for fusion genes assessment in the diagnostics of pediatric B-cell acute lymphoblastic leukemia","volume":"3","author":"Grioni","year":"2019","journal-title":"HemaSphere"},{"key":"10.1016\/j.humpath.2026.106105_bib29","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.pathol.2024.09.009","article-title":"Next-generation sequencing RNA fusion panel for the diagnosis of haematological malignancies","volume":"57","author":"Ngo","year":"2025","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2026.106105_bib30","doi-asserted-by":"crossref","first-page":"5629","DOI":"10.1002\/cam4.4101","article-title":"Mutational profiling in acute lymphoblastic leukemia by RNA sequencing and chromosomal genomic array testing","volume":"10","author":"Yeung","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.humpath.2026.106105_bib31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12920-020-00739-4","article-title":"Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics","volume":"13","author":"Engvall","year":"2020","journal-title":"BMC Med Genom"},{"key":"10.1016\/j.humpath.2026.106105_bib32","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000522","article-title":"Performances of targeted RNA sequencing for the analysis of fusion transcripts, gene mutation, and expression in hematological malignancies","volume":"5","author":"Hayette","year":"2021","journal-title":"HemaSphere"},{"key":"10.1016\/j.humpath.2026.106105_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.854098","article-title":"Technical validation and clinical utility of an NGS targeted panel to improve molecular characterization of pediatric acute leukemia","volume":"9","author":"Vicente-Garc\u00e9s","year":"2022","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.humpath.2026.106105_bib34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s40291-025-00779-5","article-title":"Effective utilization of a customized targeted hybrid capture RNA sequencing in the routine molecular categorization of adolescent and adult B-Lineage acute lymphoblastic leukemia: a real-world experience","volume":"29","author":"Sreedharanunni","year":"2025","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.humpath.2026.106105_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jmoldx.2018.09.002","article-title":"Clinical evaluation of massively parallel RNA sequencing for detecting recurrent gene fusions in hematologic malignancies","volume":"21","author":"Kim","year":"2019","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.humpath.2026.106105_bib36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/hon.2709","article-title":"Detection of recurrent, rare, and novel gene fusions in patients with acute leukemia using next-generation sequencing approaches","volume":"38","author":"Kim","year":"2020","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.humpath.2026.106105_bib37","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s40291-022-00581-7","article-title":"Clinical utility of implementing a frontline NGS-based DNA and RNA fusion panel test for patients with suspected myeloid malignancies","volume":"26","author":"Bhai","year":"2022","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.humpath.2026.106105_bib38","first-page":"1479","article-title":"Anchored multiplex PCR for targeted next-generation sequencing","volume":"20","author":"Zheng","year":"2014","journal-title":"Nat Med (N Y, NY, U S)"},{"key":"10.1016\/j.humpath.2026.106105_bib39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cancergen.2020.12.004","article-title":"RNA-based next generation sequencing complements but does not replace fluorescence in situ hybridization studies for the classification of aggressive B-Cell lymphomas","volume":"252\u2013253","author":"Wang","year":"2021","journal-title":"Cancer Genet"},{"key":"10.1016\/j.humpath.2026.106105_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17213458","article-title":"Comparative analysis of targeted RNA-Seq and optical genome mapping for detecting gene rearrangements in acute leukemia","volume":"17","author":"Ok","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2026.106105_bib41","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1182\/bloodadvances.2022007583","article-title":"Optical genome mapping in acute myeloid leukemia: a multicenter evaluation","volume":"7","author":"Levy","year":"2023","journal-title":"Blood Adv"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T16:54:23Z","timestamp":1778086463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726000742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":41,"alternative-id":["S0046817726000742"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106105","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNA NGS testing provides additional diagnostic and prognostic information over metaphase karyotyping in routine clinical evaluation of acute leukemias and chronic myeloid neoplasms","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106105"}}